Pfizer Announces Discontinuation of Twice-Daily Weight Loss Pill – What You Need to Know
Pfizer Abandons Twice-Daily Weight Loss Pill After Trial Results Pfizer announced on Friday that it would discontinue developing the twice-daily version of its experimental weight loss pill. The decision followed a mid-stage clinical study that showed obese patients taking the drug experienced weight loss but grappled with intolerable side effects. This move has set back …